Karu Jayathilake

3.3k total citations · 1 hit paper
42 papers, 2.1k citations indexed

About

Karu Jayathilake is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Karu Jayathilake has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Biological Psychiatry. Recurrent topics in Karu Jayathilake's work include Schizophrenia research and treatment (22 papers), Tryptophan and brain disorders (9 papers) and Bipolar Disorder and Treatment (7 papers). Karu Jayathilake is often cited by papers focused on Schizophrenia research and treatment (22 papers), Tryptophan and brain disorders (9 papers) and Bipolar Disorder and Treatment (7 papers). Karu Jayathilake collaborates with scholars based in United States, Japan and Brazil. Karu Jayathilake's co-authors include Herbert Y. Meltzer, Tomiki Sumiyoshi, Sandra J. Hufeisen, S Steinberg, Paul Ernsberger, Bryan L. Roth, Wesley K. Kroeze, Chan‐Hyung Kim, A. Elif Anıl Yağcıoğlu and Ajanta Roy and has published in prestigious journals such as PLoS ONE, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Karu Jayathilake

41 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

2003 637 citations Wesley K. Kroeze, Sandra J. Hufeisen et al. Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karu Jayathilake United States	20	1.1k	582	501	261	245	42	2.1k
A.J.M. Loonen Netherlands	26	916 0.8×	581 1.0×	369 0.7×	286 1.1×	251 1.0×	161	2.4k
Eduard Parellada Spain	30	1.4k 1.3×	384 0.7×	324 0.6×	342 1.3×	180 0.7×	98	2.5k
Belén Arranz Spain	24	841 0.8×	568 1.0×	327 0.7×	251 1.0×	267 1.1×	101	1.8k
Katherine Beck United Kingdom	20	1.2k 1.1×	477 0.8×	403 0.8×	518 2.0×	331 1.4×	37	2.6k
Fernando Caravaggio Canada	26	1.0k 0.9×	549 0.9×	334 0.7×	390 1.5×	196 0.8×	98	2.3k
W.W. Fleischhacker Austria	27	1.5k 1.4×	321 0.6×	369 0.7×	240 0.9×	409 1.7×	58	2.5k
L. Lindström Sweden	20	865 0.8×	718 1.2×	619 1.2×	287 1.1×	150 0.6×	43	2.2k
Enrico Lattuada Italy	25	837 0.8×	571 1.0×	282 0.6×	253 1.0×	325 1.3×	44	1.6k
Zhenghui Yi China	28	691 0.6×	256 0.4×	657 1.3×	501 1.9×	290 1.2×	114	2.3k
Yuya Mizuno Japan	18	911 0.8×	244 0.4×	196 0.4×	183 0.7×	192 0.8×	35	1.7k

Countries citing papers authored by Karu Jayathilake

Since Specialization

Citations

This map shows the geographic impact of Karu Jayathilake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karu Jayathilake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karu Jayathilake more than expected).

Fields of papers citing papers by Karu Jayathilake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karu Jayathilake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karu Jayathilake. The network helps show where Karu Jayathilake may publish in the future.

Co-authorship network of co-authors of Karu Jayathilake

This figure shows the co-authorship network connecting the top 25 collaborators of Karu Jayathilake. A scholar is included among the top collaborators of Karu Jayathilake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karu Jayathilake. Karu Jayathilake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nasr, Suhayl, Karu Jayathilake, Stefanie Rassnick, et al.. (2024). Lack of Efficacy of JNJ-18038683 on Cognitive Impairment in Patients With Stable Bipolar Disorder. Journal of Clinical Psychopharmacology. 44(5). 481–491.

Kim, Ahra, Karu Jayathilake, Stephany N. Duda, et al.. (2022). Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000–2016. AIDS Patient Care and STDs. 36(9). 343–355. 5 indexed citations

Musick, Beverly, Steven A. Brown, Karen Malateste, et al.. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium. Journal of Biomedical Informatics. 131. 104110–104110. 3 indexed citations

Meltzer, Herbert Y., et al.. (2018). A within‐subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery. CNS Neuroscience & Therapeutics. 24(7). 641–651. 2 indexed citations

Fink, Valeria, Cathy A. Jenkins, Jessica L. Castilho, et al.. (2018). Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America. Infectious Agents and Cancer. 13(1). 16–16. 13 indexed citations

Crabtree‐Ramírez, Brenda, Bryan E. Shepherd, Megan Turner, et al.. (2015). Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America. AIDS and Behavior. 19(9). 1599–1608. 3 indexed citations

Carriquiry, Gabriela, Valeria Fink, John R. Koethe, et al.. (2015). Mortality and loss to follow‐up among HIV‐infected persons on long‐term antiretroviral therapy in Latin America and the Caribbean. Journal of the International AIDS Society. 18(1). 20016–20016. 47 indexed citations

Sumiyoshi, Chika, Aygün Ertuğrul, A. Elif Anıl Yağcıoğlu, et al.. (2014). Language-dependent performance on the letter fluency task in patients with schizophrenia. Schizophrenia Research. 152(2-3). 421–429. 11 indexed citations

Horiguchi, Masakuni, et al.. (2012). D1 receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats. Behavioural Brain Research. 238. 36–43. 38 indexed citations

10.

Horiguchi, Masakuni, et al.. (2012). Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist. Neuropsychopharmacology. 37(10). 2175–2183. 40 indexed citations

11.

Lee, Myung, Karu Jayathilake, Jin Dai, & Herbert Y. Meltzer. (2010). Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration. Psychiatry Research. 185(3). 328–333. 37 indexed citations

12.

Meltzer, Herbert Y., William V. Bobo, Ajanta Roy, et al.. (2008). A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia. The Journal of Clinical Psychiatry. 69(2). 274–285. 113 indexed citations

13.

Sumiyoshi, Tomiki, Sohee Park, Karu Jayathilake, et al.. (2007). Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: A randomized, double-blind, placebo-controlled study. Schizophrenia Research. 95(1-3). 158–168. 109 indexed citations

14.

Sumiyoshi, Tomiki, Jin Dai, Karu Jayathilake, Myung Lee, & Herbert Y. Meltzer. (2005). Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia. The International Journal of Neuropsychopharmacology. 8(3). 451–455. 27 indexed citations

15.

Sumiyoshi, Chika, Tomiki Sumiyoshi, Ajanta Roy, Karu Jayathilake, & Herbert Y. Meltzer. (2005). Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia. The International Journal of Neuropsychopharmacology. 9(6). 677–677. 28 indexed citations

16.

Sumiyoshi, Tomiki, A. Elif Anıl Yağcıoğlu, Jin Dai, et al.. (2004). Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms. The International Journal of Neuropsychopharmacology. 7(1). 1–8. 135 indexed citations

17.

Kroeze, Wesley K., Sandra J. Hufeisen, S Steinberg, et al.. (2003). H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs. Neuropsychopharmacology. 28(3). 519–526. 637 indexed citations breakdown →

18.

Sumiyoshi, Tomiki, Karu Jayathilake, & Herbert Y. Meltzer. (2003). A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia. Schizophrenia Research. 62(1-2). 65–72. 13 indexed citations

19.

Kim, Chan‐Hyung, Karu Jayathilake, & Herbert Y. Meltzer. (2002). Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophrenia Research. 60(1). 71–80. 199 indexed citations

20.

Meltzer, Herbert Y., Tomiki Sumiyoshi, & Karu Jayathilake. (2001). Melperone in the treatment of neuroleptic-resistant schizophrenia. Psychiatry Research. 105(3). 201–209. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact